# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst David Roman initiates coverage on Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price...
Citigroup analyst Joanna Wiensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $128 t...
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.
- Reuters